ALLIANCEBERNSTEIN L.P. - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 205 filers reported holding NPS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$64,801,000
+3.3%
1,811,609
-24.9%
0.05%
+1.9%
Q3 2014$62,712,000
-31.0%
2,412,013
-12.3%
0.05%
-31.2%
Q2 2014$90,937,000
+21.7%
2,751,488
+10.2%
0.08%
+18.5%
Q1 2014$74,713,000
+11.6%
2,496,246
+13.2%
0.06%
+8.3%
Q4 2013$66,922,000
+306.7%
2,204,276
+326.1%
0.06%
+275.0%
Q3 2013$16,456,000
+455.6%
517,332
+163.7%
0.02%
+433.3%
Q2 2013$2,962,000196,1580.00%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,839,263$27,791,0009.88%
Broadfin Capital, LLC 1,696,754$25,638,0005.02%
HARVEY CAPITAL MANAGEMENT INC 1,057,800$15,982,0004.96%
ArrowMark Colorado Holdings LLC 578,750$8,745,0002.35%
FCG ADVISORS, LLC 140,805$2,128,0001.73%
EMERALD MUTUAL FUND ADVISERS TRUST 600,471$9,073,0001.54%
OAK RIDGE INVESTMENTS LLC 2,782,714$42,047,0001.32%
Lisanti Capital Growth, LLC 139,340$2,510,0001.20%
EMERALD ADVISERS, LLC 1,193,198$18,029,0001.10%
SECTORAL ASSET MANAGEMENT INC 2,302,428$34,790,0001.03%
View complete list of NPS PHARMACEUTICALS INC shareholders